BioCryst's injectable flu treatment approved by FDA; stock jumps

December 22, 2014 2:15 PM

6 0

BioCryst's injectable flu treatment approved by FDA; stock jumps

Durham's BioCryst Pharmaceuticals received approval for peramivir, an injectable flu treatment the company developed with federal government grants.

It is the first new new antiviral treatment for the flue approved by the U.S. Food and Drug Administration in 15 years. Also, this is the first drug developed by BioCryst (Nasdaq: BCRX) to receive approval in the United States.

Read more

To category page

Loading...